IBM and EU Partners Create a Better Way to Fight ...( EuResist HIV Treatment Prediction Too...),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
IBM and EU Partners Create a Better Way to Fight AIDS Virus
Date:6/2/2009
EuResist HIV Treatment Prediction Tool Wins Top Honors in Computerworld Honors Program
WASHINGTON, June 2 /PRNewswire-FirstCall/ -- IBM (NYSE: IBM) today announced it was selected for its contributions to the EuResist research project for AIDS treatment as a Computerworld Honors Program Laureate for 2009.
(Logo: http://www.newscom.com/cgi-bin/prnh/20090416/IBMLOGO )
Developed by IBM researchers in Haifa, Israel, the project's new technologies and mathematical models are providing a smarter and more efficient way to choose the best drugs combinations for any given HIV genetic variant. EuResist is a powerful online system that helps doctors choose the treatment with the highest probability of halting virus replication and impairing evolution of drug resistance.
Although there have been tremendous leaps and bounds in the management of the virus that causes AIDS, HIV has the ability to develop resistance to any antiretroviral compound. This means that doctors need to continuously monitor and prescribe new therapies for the treatment to remain effective. Keeping HIV under control is dependant on choosing the right combination of drugs that work for the longest period of time.
EuResist is the first and only freely available data-driven computational method that predicts the success of a treatment regimen against any given HIV genotype, based not only on viral genotype information, but using analytic technologies to take into account treatment response information fr
'/>"/>
| SOURCE IBM Corporation Copyright©2009 PR Newswire. All rights reserved |
Related medicine technology :
1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
5. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
6. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
7. UNICEF Partners With Causes on Facebook to Launch Charity Gift Feature
8. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
9. iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product
10. Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
11. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
Post Your Comments:
(Date:11/25/2009)...re-FirstCall/--Pharmasset,Inc.(Nasdaq: VRUS ),acli...ing,developingandcommercializingnoveldrugstotreatv...lyearendedSeptember30,2009.AtSeptember30,2009Pharm...tterminvestments. ,, PipelineUpdateand2009High..., InlateNovember2009,anindependentDataMonitoringCo...
(Date:11/25/2009)...wswire-FirstCall/--Formanyofthemillionsofhearingim...treated hearingloss ,theholidaysmaynotbeallthathap...rvicepresidentofHearUSA(Amex: EAR ),oneofAmerica,s...udieshavelinkedhearinglosstostress,frustration,and...daygatheringswithfamiliesandfriends,whenmanyofthos...
(Date:11/25/2009)...portlinker.comannouncesthatanewmarketresearchrepor...talDevicesMarketAnalysisandForecaststo2015 ,, ...s-Dental-Devices-Market-Analysis-and-Forecasts-to-...alysisandForecaststo2015 ,, Summary ,, Thi...ddatarelatingtotheUSdentaldevicesmarket.Italsooffe...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Partnership for Prescription Assistance Prepared to Help Wyoming Workers Hurt by Recession 48650 1Partnership for Prescription Assistance Prepared to Help Wyoming Workers Hurt by Recession 48650 2Partnership for Prescription Assistance Prepared to Help Wyoming Workers Hurt by Recession 48650 3Partnership for Prescription Assistance Prepared to Help Wyoming Workers Hurt by Recession 48650 4New American College of Surgeons risk calculator determines colorectal surgery risk 48647 1New American College of Surgeons risk calculator determines colorectal surgery risk 48647 2New American College of Surgeons risk calculator determines colorectal surgery risk 48647 3Brown 26 Toland Announces 2008 Financial Results 48645 1Brown 26 Toland Announces 2008 Financial Results 48645 2...Multicenter Trial Will Test Ability of Adecatumuma...tients with Liver Metastases , , BETHESDA, Md., M...pharmaceutical company developing novel, proprieta...ation and autoimmune diseases, today announced the...trial of its human anti-EpCAM IgG1 antibody adecat...
...Innocoll, Inc., a privately-held biopharmaceutical... dosed in the second of two ongoing U.S. phase 3 c...diary, Innocoll Technologies Ltd, to investigate C...ention of surgical site infections. , , The trial...ites across the U.S. and has enrolled 600 patients...
Other Medicine Technology:Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients 2Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients 3Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients 4Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients 5Innocoll Announces Dosing of Last Patient in Second US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Colorectal Surgery Patients 2Innocoll Announces Dosing of Last Patient in Second US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Colorectal Surgery Patients 3(Date:11/25/2009)...v.25/PRNewswire-FirstCall/-- OnyxPharmaceuticals,...lhosttwoinvestoreventsinDecember: ,, ASHBrief...T ,, Principalinvestigatorswilldiscussdatapre...fractorymultiplemyeloma,asfeaturedatthe51stAmerica...ninNewOrleans,LA.Theteleconferencewillbeginat9:00a...
(Date:11/25/2009)....25/PRNewswire-USNewswire/--AnarticlebyJanetWoodco...ndResearch,titled"ADifficultBalance-PainManagement...eofTheNewEnglandJournalofMedicine. ,, (Logo: ht... ) ,, Inthearticle,WoodcockdiscussesFDAeffortst...sewhoneeditandmanagingtherisksposedbyvariousanalge...
(Date:11/25/2009)...ticular cancer who were treated with cisplatin-bas...uding neurological side effects and Raynaud-like p...therapy, according to a new study published online...r Institute . , Marianne Brydy, M.D., of the Dep..., in Bergen, Norway, and colleagues conducted a cr...
(Date:11/25/2009)...as too short to draw definite conclusions, experts... News) -- In diabetic patients with blocked corona...outcomes at one year whether patients undergo bypa...esearchers report. , Bypass surgery has been th...ronary artery disease. However, less invasive appr...
(Date:11/25/2009)...eurological symptoms, study finds , , W... side effects are among the potential problems fac... were treated with cisplatin-based chemotherapy, a...9 Norwegian men treated for unilateral testicular ...llow-up survey conducted from 1998 to 2002. , T...
Breaking Medicine News(10 mins):Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3[0] Onyx Pharmaceuticals Announces December 2009 Investor Events[1] FDA's Woodcock Discusses Pain Management and Drug Safety in Nov. 26, 2009 Issue of The New England Journal of Medicine[1] News brief: Long-term testicular cancer survivors at high risk for neurological side effects[1] Stenting May Equal Bypass for Diabetic Heart Patients [0] Long-Term Problems Linked to Testicular Cancer Chemo
...
Ministers and NHS Staff use demeaning terms suc...ribe patients//, according to patients' tsar.
T...Harry Cayton said such negative words shifted blam...ent flyers referring to patients who are in and ou...
... A doctor of Indian origin forged time sheets to c...ot do a day's work, the Newcastle Crown Court hear...ing hearings, the court was told that Dr Debasmita...ecause her work was not judged to be good enough. ...
... Following the recent scary outbreak of an epidemi...57:H7 which caused diarrhea// with bloody stools i...as been initiated to round up and annihilate the s...
Samples of the suspected cattle dung are being te...
... This year, the Nobel prize for medicine has been ...IT and Craig C Mello of the Harvard University//, ...ytic process proposed to occur in plants, animals ... expression, controls the activity of ‘jumping gen...
... Leading doctors and scientists warned yesterday t...uses sucking their thumbs// and walking in the wom...nfluence on the public debate over abortion.
...ession that foetuses develop into viable and poten...
... President A.P.J. Abdul Kalam Tuesday urged medica...cus more on preventive care and report //negative ...to enable medical practitioners to take well infor... institutions should also spend significant amount...
Other Medicine News:Health News:NHS Reprimanded for Demeaning Words 2Health News:Indian Origin Doctor Faces Trial for Cheating 2Health News:Nobel Prize for Gene ‘Silencing 2Health News:New foetal scans are misleading 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |